Clinical trial

Non-interventional, Postauthorization Safety Study of Ventavis for Pulmonary Arterial Hypertension (PAH)

NCT02825160

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2016-08-01

PhaseN/A

Study timeline

Study start (actual)2016-08-01Date precision: day

Registry last updated2024-08-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertension, Pulmonaryunresolved

Interventions

Ventavis (Iloprost, BAYQ6256)DRUG

Sponsors & collaborators

Bayerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02825160 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.